End-of-Life Issues for Patients With Primary or Metastatic Brain Tumors
Discussion Session 8 (time: 1 hour, 16 minutes)

The purpose of this session is to discuss the unique symptoms that occur at the end of life in patients with primary or metastatic brain tumors. Management of these symptoms will be discussed. Caregivers require special help in coping with these neurologically related symptoms at the end of life. Up to date literature will be presented and an interactive discussion will occur using case studies to share some possibilities to best manage the end of life of patients with primary or metastatic brain tumors.
Pharmacology content: 5 minutes.
Contact hours: 1.92.

Please note that the session downloading time will vary depending on the session length and your system connection speed.

Presenters:
Mary Lovely, PHD, RN (Session Coordinator)
Nurse Consultant
National Brain Tumor Foundation
San Francisco, CA
Vested interest: nothing to disclose

Terri Armstrong, MS, APRN, BC
Advanced Practice Nurse
M.D. Anderson Cancer Center
Houston, TX
Vested interest: nothing to disclose

Program Objectives
After completing this activity, the participant will be able to:

1. State the unique symptoms of end of life for patients with primary or metastatic brain tumors.
2. Explain methods to manage the symptoms at end of life.
3. Analyze the difficulty of care giving at end of life of a patient with a primary or metastatic brain tumor compared to a patient without neurological deficits.

CE Evaluation
After viewing the entire session, download and complete the CE evaluation and commitment to change statement. The evaluation is available for download as a Microsoft Word form or PDF. The Word form contains editable fields that can be completed electronically. Simply type your responses, save the completed version, print the form, and mail it to ONS.

Word doc
PDF

Download Slides
PDF versions of the session slides are available for you to download.

Slide note pages (Armstrong)
Slide note pages (Lovely)

Supported by a grant from Ortho Biotech Products, LP.